Digestive System Channel
Topics
Medications
Quicklinks
Related Channels

TriLyte Warnings and Precautions

Specific Precautions and Warnings With TriLyte

Some warnings and precautions to be aware of prior to taking this drug include the following:
 
  • Do not add any other ingredients to TriLyte, including flavorings or other liquids or beverages. You may use one of the flavor packs that came with the medication. Only use the flavor packs with this medication. Throw out any flavor packs you do not use.
     
  • TriLyte should be used with caution in people with an inflammatory bowel disease known as ulcerative colitis. If you have this condition, talk to your healthcare provider before starting this laxative.
     
  • If severe abdominal swelling (distention), bloating, or discomfort occurs while using TriLyte, temporarily stop taking it, or try drinking each portion more slowly until the symptoms lessen. Some temporary abdominal discomfort and swelling are normal when you first start drinking TriLyte, especially before your first bowel movement.
     
  • This product does not contain calories. There have been cases of low blood sugar (hypoglycemia) due to lack of food intake in children less than two years of age using this medication. Monitor your child closely, and contact his or her healthcare provider if you notice any symptoms of hypoglycemia during TriLyte treatment. Symptoms may include:
     
    • Shakiness
    • Dizziness
    • Sweating
    • Sleepiness
    • Confusion.
 
  • Children may be at risk for developing dehydration and low blood potassium (hypokalemia) while using this medication. Symptoms of dehydration may include:
     
    • Decreased urination or dry diapers
    • Dry mouth, tongue, or lips
    • A sunken fontanelle ("soft spot" on the skull) in babies
    • Fussiness, irritability, or excessive crying
    • Less activity than normal.
 
  • People with difficulty swallowing, with an impaired gag reflex, who are unconscious or partly conscious, or who otherwise may be at risk of vomiting and potentially breathing in (aspirating) TriLyte solution should be watched closely during its administration, especially if TriLyte is given through a nasogastric (NG) tube.
     
  • People with a hole or blockage in the intestines (bowel perforation or obstruction) should not use this medication. If you have possible symptoms, your healthcare provider will need to perform tests to make sure you do not have these conditions before using TriLyte. Symptoms may include:
     
    • Nausea and vomiting
    • Severe abdominal (stomach) pain
    • Abdominal distention or swelling
    • Abdominal pain and cramping.
 
  • Rare cases of an allergic reaction have been reported in some people using TriLyte, including a skin rash, hives, or itching. If you experience such problems while using this product, stop taking it and talk to a healthcare provider.
     
  • TriLyte is likely to react with other oral medications taken within one hour of starting treatment (see TriLyte Drug Interactions).
     
  • This product is considered a pregnancy Category C medication. This means that it may not be safe for use during pregnancy, although the full risks are currently unknown. Talk to your healthcare provider about the risks and benefits of using TriLyte when pregnant (see TriLyte and Pregnancy).
     
  • It is unknown if TriLyte passes through breast milk, though it is not thought to do so. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to beginning treatment (see TriLyte and Breastfeeding).
     

TriLyte Medication Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.